SPRYT, the award-winning Irish healthtech company behind Asa, the AI receptionist transforming patient access to care, has announced a strategic investment from MediDrive, the US-based healthcare transport and logistics innovator.
This partnership marks a pivotal moment for SPRYT as it scales globally across health systems in the US, UK, Europe, and the Middle East. Together, SPRYT and MediDrive will integrate intelligent patient scheduling, automated communication, and transport booking into one seamless experience, ensuring that when SPRYT says “we’re making the world show up to care,” it means it.
“Asa has already proven it can increase attendance rates by more than 160 percent in the NHS,” said Neill Dunwoody, Co-Founder and COO of SPRYT. “By combining our AI scheduling and engagement technology with MediDrive’s nationwide healthcare transport capabilities, we’re not just helping people book care, we’re helping them get there. This partnership removes the final barrier between intention and attendance.”
Through this collaboration, MediDrive’s will integrate directly with Asa, allowing patients to schedule and manage transport to their appointments automatically, whether via car, shuttle, or non-emergency medical vehicle. For hospitals, clinics, and health systems, it means fewer missed appointments, reduced administrative burden, and a measurable impact on care delivery outcomes.
SPRYT is redefining patient engagement through AI,” said Alan J. Murray, President and CEO of MediDrive. “Their visionaligns perfectly with ours — using technology to make healthcare more accessible and efficient. We believe this partnership provides both SPRYT and MediDrive with the opportunity to create scale and impact healthcare globally.”
The investment will accelerate SPRYT’s international expansion, with deployments already underway with major US healthcare providers and discussions underway in MENA, and Europe.
SPRYT’s AI platform is currently used in the NHS and has been recognized with the Overall National Enterprise Award of Ireland 2025, HIMSS Pitchfest Winner, and UK MedTech Startup of the Year.
